Product reference notes for new serological assays to diagnose SARS-CoV-2

New serological assays for detection of SARS-CoV-2 infection are added to UNICEF Supply Catalogue.

About

New serological assays, rapid antigen (Ag) tests for COVID-19 diagnosis have been added to the UNICEF diagnostics portfolio and are now available for UNICEF programme countries and procurement services partners in addition to manual and automated real-time PCR tests. Like all other COVID-19 diagnostics procured by Supply Division, new products are quality-assured, i.e. either listed under the WHO Emergency Use List (EUL) or holding the FDA Emergency Use Authorization (EUA).

The new rapid antigen diagnostic tests for COVID-19 diagnosis are available with very short FCA lead times, which is critical for countries struggling with COVID-19 supply shortages and interruptions. More rapid antigen diagnostic tests will be added as they become available.

Product reference notes for all new COVID-19 diagnostics are available and useful for evaluators and decision-makers. The notes include comprehensive technical and commercial information, such as kit contents, storage conditions, as well as price and indicative lead time.

Download document

(PDF, 158,17 KB) (PDF, 72,66 KB)